Endotoxin Adsorption Therapy for Septic Shock Using Polymyxin B-Immobilized Fibers (PMX): Evaluation by High-sensitivity Endotoxin Assay and Measurement of the Cytokine Production Capacity
- 1 February 2006
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 10 (1) , 12-18
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltrationCritical Care Medicine, 1995
- Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swineCritical Care Medicine, 1993
- Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patientsCritical Care Medicine, 1993
- Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.Journal of Experimental Medicine, 1990
- Increase in National Hospital Discharge Survey Rates for Septicemia— United States, 1979-1987JAMA, 1990
- Ineffectiveness of High-dose Methylprednisolone in Preventing Parenchymal Lung Injury and Improving Mortality in Patients with Septic ShockAmerican Review of Respiratory Disease, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockNew England Journal of Medicine, 1984